Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 734-738

  Nakamura, Tsutomu ^a   Hashimoto, Yukiya ^a   Kokuryo, Toshiyuki ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Fosfomycin; Imipenem cilastatin; Nephrotoxicity; Protective effect; Renal handling; Vancomycin

Indexed keywords

4 AMINOHIPPURIC ACID; CILASTATIN PLUS IMIPENEM; CIMETIDINE; CREATININE; FOSFOMYCIN; HABEKACIN; UREA; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG ACCUMULATION; DRUG EFFECT; DRUG ELIMINATION; DRUG EXCRETION; DRUG TRANSPORT; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS INFECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CILASTATIN; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FOSFOMYCIN; IMIPENEM; KIDNEY; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, WISTAR; VANCOMYCIN;

EID: 0031801552     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011971019868     Document Type: Article

References (18)

1. F. V. Cook and W. E. Farrar. Vancomycin revisited. Ann. Intern. Med. 88:813-818 (1978).
2. W. G. Leader, M. H. H. Chandler, and M. Castiglia. Pharmacokinetic optimisation of vancomycin therapy. Clin. Pharmacokin. 28:327-342 (1995).
3. T. Toyoguchi and Y. Nakagawa. Nephrotoxicity and drug interaction of vancomycin (2). Folia Pharmacol. Jpn. 107:225-235 (1996).
4. T. Nakamura, M. Takano, M. Yasuhara, and K. Inui. In-vivo clearance study of vancomycin in rats. J. Pharm. Pharmacol. 48:1197-1200 (1996).
5. R. Hori, Y. Tanigawara, Y. Saito, Y. Hayashi, T. Aiba, K. Okumura, and A. Kamiya. Moment analysis of drug disposition in kidney: transcellular transport kinetics of p-aminohippurate in the isolated perfused rat kidney. J. Pharm. Sci. 77:471-476 (1988).
6. S. Hall and M. Rowland. Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 232:263-268 (1985).
7. T. Nakamura, T. Kokuryo, M. Takano, and K. Inui. Renal excretion of vancomycin in rats with acute renal failure. J. Pharm. Pharmacol. 49:154-157 (1997).
8. R. Hori, Y.-L. He, Y. Saito, A. Kamiya, and Y. Tanigawara. Moment analysis of drug disposition in kidney. V: in vivo transepithelial transport of p-aminohippurate in rat kidney. J. Pharmacokin. Biopharm. 19:51-70 (1991).
9. J. B. Pritchard and D. S. Miller. Mechanisms mediating renal secretion of organic anions and cations. Physiol. Rev. 73:765-796 (1993).
10. M. Takano, K. Inui, T. Okano, and R. Hori. Cimetidine transport in rat renal brush border and basolateral membrane vesicles. Life Sci. 37:1579-1585 (1985).
11. H. Kumon, A. Mizuno, Y. Nasu, M. Tsugawa, M. Kishi, and H. Ohmori. Pharmacokinetics of arbekacin in healthy volunteers and patients with renal insufficiency. Jpn. J. Antibiotics 42:200-207 (1989).
12. V. U. Collier, P. S. Lietman, and W. E. Mitch. Evidence for luminal uptake of gentamicin in the perfused rat kidney. J. Pharmacol. Exp. Ther. 210:247-251 (1979).
13. F. J. Silverblatt and C. Kuehn. Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15:335-345 (1979).
14. R. P. Wedeen, V. Batuman, C. Cheeks, E. Marquet, and H. Sobel. Transport of gentamicin in rat proximal tubule. Lab. Invest. 48:212-223 (1983).
15. D. Beauchamp, P. Gourde, M. Simard, and M. G. Bergeron. Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 36:2204-2210 (1992).
16. R. Marre, E. Schulz, D. Hedtke, and K. Sack. Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity. Infection 13:190-192 (1985).
17. M. Saito, T. Masaki, H. Kato, and K. Numasaka. A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloro-platinum (CDDP)-induced nephrotoxicity. Acta Urol. Jpn. 34:782-789 (1988).
18. E. Gruss, J. F. Tomás, C. Bernis, F. Rodriguez, J. A. Traver, and J. M. Fernández-Rañada. Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis. Bone Mallow Transplant. 18:761-765 (1996).